WO1997006851A1 - Threshold templating for digital agc - Google Patents
Threshold templating for digital agc Download PDFInfo
- Publication number
- WO1997006851A1 WO1997006851A1 PCT/US1996/013181 US9613181W WO9706851A1 WO 1997006851 A1 WO1997006851 A1 WO 1997006851A1 US 9613181 W US9613181 W US 9613181W WO 9706851 A1 WO9706851 A1 WO 9706851A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ofthe
- threshold
- sensing threshold
- electrical activity
- cardioverter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/3702—Physiological parameters
- A61N1/3704—Circuits specially adapted therefor, e.g. for sensitivity control
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/901—Suppression of noise in electric signal
Definitions
- the present invention relates generally to implantable medical devices, and more particularly, to systems such as automatic gain control systems for automatically adjusting the sensing threshold in cardiac rhythm management devices, such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability.
- cardiac rhythm management devices such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability.
- Cardiac rhythm management devices such as pacemakers, cardioverter/defibrillators, and cardioverter/defibrillators with pacing capability typically include a system for detecting dangerous cardiac arrhythmia conditions in the heart, such as bradycardia, tachycardia, and fibrillation by measuring the time interval between consecutive cardiac depolarizations.
- Cardiac rhythm management devices receive a sensed cardiac signal comprising electrical activity ofthe heart and detect cardiac depolarizations in the electrical activity when an amplitude ofthe electrical activity exceeds a predetermined amplitude level or "sensing threshold.”
- the sensing threshold may be fixed, or may vary over time.
- a fixed sensing threshold is not appropriate for detecting certain arrhythmias, such as polymorphic tachycardia and fibrillation, wherein extreme variations occur in the amplitude ofthe electrical activity during the arrhythmia.
- arrhythmias such as polymorphic tachycardia and fibrillation
- the problem of tracking variations in the amplitude ofthe electrical activity is further complicated when the cardiac rhythm management device delivers pace pulses to the heart, which cause invoked responses which are quite high in amplitude as compared to normal cardiac depolarizations.
- One approach to compensate for problems associated with a fixed sensing threshold is to program the sensing threshold at a value determined by the attending physician after careful study ofthe variety of amplitudes in cardiac signal activity experienced by a patient.
- a sensing threshold is programmed into the cardiac rhythm management device, and any cardiac signal amplitude larger than the programmed sensing threshold is considered a cardiac depolarization. If, however, the programmed sensing threshold is set too high and the cardiac signal amplitude decreases significantly, as is often the case in fibrillation, the cardiac rhythm management device may not sense the arrhythmia. If the programmed sensing threshold is set too low, the device may over-sense.
- a system designed to detect ventricular depolarizations may erroneously detect atrial depolarizations (P-waves) or ventricular recovery (T-waves).
- Bandpass filtering can be used to partially eliminate erroneous detection ofthe P-waves and T-waves in a R-wave detection system. If, however, the band of frequencies passed by the bandpass filtering is too narrow, certain fibrillation signals may not be detected.
- Another approach to compensate for the above problems is to set the sensing threshold proportional to the amplitude ofthe sensed cardiac signal each time a cardiac depolarization is sensed.
- the sensing threshold is then allowed to decrease over time between consecutively sensed cardiac depolarizations so that if the sensed cardiac signal amplitude decreases significantly, the cardiac rhythm management device is still able to detect the lower level amplitude ofthe cardiac signal.
- Adjusting the sensing threshold to an appropriate level with this approach becomes difficult if the patient requires pacing due to a bradycardia condition. For example, in a system that senses R-waves according to this approach, the sensing threshold may be adjusted to one-half of the R-wave amplitude when an R-wave is sensed.
- the invoked response due to a first pacing pulse can cause the sensing threshold to be set so high that a second spontaneous R-wave is not sensed. Because the system does not sense the second spontaneous R-wave, a second pacing pulse is delivered to the patient inappropriately.
- the Kelly et al. patent discloses an implantable cardioverter/defibrillator with pacing capability wherein the sensing threshold is automatically adjusted to a value proportional to the amplitude ofthe sensed cardiac signal. The sensing threshold continuously decreases between sensed cardiac depolarizations to ensure that a lower level cardiac signal will be detected. However, after a pacing pulse is delivered by the Kelly et al.
- the sensing threshold is set to a fixed value, and held at the fixed value for a predetermined period of time, so that the sensing threshold is not affected by the cardiac response invoked by the pacing pulse. After a predetermined period of time, the sensing threshold is decreased, just as after a spontaneous cardiac depolarization.
- an R-wave detector automatically adjusts the detecting threshold in response to the R-wave amplitude. The adjustment ofthe threshold is disabled for a predetermined period following the delivery of each pacing pulse. Thereafter, the sensing threshold is returned to a lower threshold level to allow detection of lower level R-waves indicative of tachyrhythmia conditions.
- a sensitivity control is used for controlling a sensing threshold in a cardiac control device such as a pacemaker, cardioversion and/or cardiac defibrillation device.
- a sensing threshold is set to a low value.
- the sensing threshold is computed as a function ofthe amplitude ofthe R-wave.
- the sensing threshold is preferably set to 75% ofthe amplitude ofthe R-wave.
- the sensing threshold is then decreased in uniform steps. The uniform steps may be fixed decrements or percentage reductions.
- 4,940,054 discloses a cardioversion device having three sensitivities.
- a first, medium sensitivity is used for the detection of sinus rhythm and ventricular tachycardia.
- a second, higher sensitivity is designed for differentiating ventricular fibrillation from asystole.
- a third, lower sensitivity is used to differentiate between R-waves and high amplitude current of injury T-waves which occur after shocking.
- One of these three sensitivities is selected as a function ofthe status ofthe device, such as during a period of suspected tachycardia or a post shock period, and the selected sensitivity must be maintained at least until the next cycle.
- the Dissing et al. U.S. Patent No. 5,370,124 discloses a cardiac rhythm management device having circuitry for automatically adapting the detection sensitivity to the cardiac signal.
- the detection sensitivity is adjusted by either amplifying the electrical signal supplied to the threshold detector with a variable gain given a permanently prescribed threshold or by varying the threshold itself.
- the effective threshold is based on an average value formed over a time interval corresponding to the duration ofa few breaths.
- a switching hysteresis is generated having a lower limit value and an upper limit value, where the threshold is reset only when the average value falls below the lower limit value or exceeds the upper limit value.
- the limit values ofthe switching hysteresis are varied with the variation ofthe threshold, but the relationship ofthe limit values to the threshold remain unvaried.
- a beat-to-beat variance of signal heights of successive input electrical signals are used for forming an average value.
- the sensing threshold is raised by a predetermined amount if the variance exceeds the predetermined variance value.
- the Carroll et al. U.S. Patent No. 4,972,835 discloses an implantable cardiac defibrillator which includes switched capacitor circuitry for amplifying the cardiac electrical signal with non-binary gain changing steps. Three stages of gain are used to increase the gain approximately 1.5 each increment.
- 5,103,819 discloses a state machine for automatically controlling gain ofthe sensing function in an implantable cardiac stimulator.
- the rate of gain adjustment is dependent on the present sensed conditions and on the prior state ofthe heart. Different rates of adjustment are selected under varying conditions so that the gain ofthe sense amplifier is adjusted without significant overshoot. Multiple effective time constants are used for different conditions by basing the rate of adjustment ofthe sense amplifier gain on the path traversed in the state machine.
- the present invention provides a method and system for automatically adjusting a sensing threshold in a cardioverter/defibrillator which receives electrical activity ofthe heart and provides shock pulses in response to the received electrical activity.
- the electrical activity is amplified.
- Cardiac events representing depolarizations in the electrical activity which exceed a variable sensing threshold are detected.
- Amplitudes ofthe amplified electrical activity are tracked.
- the variable sensing threshold is adjusted to a level proportional to the amplitude ofthe amplified electrical activity ofa current detected cardiac event.
- the variable sensing threshold is decreased from the level in discrete steps until the variable sensing threshold is at a low threshold value.
- the discrete steps are grouped into step groups. Each step group decreases the variable sensing threshold by a defined percentage.
- the variable sensing threshold is preferably adjusted with a template generation circuit.
- the template generation circuit preferably acquires the depolarization peak value, or after a pace or shock pulse, the variable sensing threshold is set to a selected relatively high threshold value.
- the selected relatively high threshold value is one binary number below the maximum value ofthe variable threshold.
- the template generation circuit adjusts the variable sensing threshold to a level which is a percentage of a peak value ofthe amplitude ofthe amplified electrical activity ofthe current detected cardiac event. The percentage is typically approximately 75%.
- the template generation circuit preferably adjusts the variable sensing threshold to the level prior to the end ofa new sensing refractory period caused by a detected cardiac event.
- the template generation circuit preferably adjusts the variable sensing threshold to the level at the end ofa paced/shock refractory period resulting from a pace or shock pulse.
- the template generation circuit preferably calculates an amount of drop for a discrete step using integer math to achieve a piecewise linear approximation ofa geometric progression.
- the geometric progression preferably represents an exponential decay curve.
- the defined percentage drop for each step group is typically approximately 50%. In one embodiment ofthe present invention, each step group includes at least four discrete steps.
- the system ofthe present invention preferably comprises a decay rate controller for varying a time width of each discrete step based on operating conditions ofthe cardioverter/defibrillator to control the decay of rate ofthe variable sensing threshold.
- the operating conditions include bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
- the decay rate controller preferably varies the time width to produce a relatively fast decay rate when the cardioverter/defibrillator is operating under tachyarhythmia sensing conditions.
- the decay of rate controller varies the time width as a function of a bradycardia pacing rate.
- a preferred embodiment ofthe decay rate controller varies the time width under bradycardia pacing conditions based on the time between each pacing pulse, a programmed paced refractory period, and the number of discrete steps to go from said level to the low threshold value.
- Figure 1 is a block diagram of a dual chamber cardioverter/defibrillator according to the present invention.
- Figure 2 is a logical block diagram of an AGC filter and digitizing circuit according to the present invention.
- Figure 3 is a timing diagram illustrating the sensed refractory used in the cardioverter/defibrillator of Figure 1.
- Figure 4 is a timing diagram illustrating the paced/shock refractory used in the cardioverter/defibrillator of Figure 1.
- Figure 5 is a logical block diagram of a gain control circuit according to the present invention.
- Figure 6 is a timing diagram illustrating a piecewise linear approximation of an exponential decay ofthe variable sensing threshold according to the present invention.
- Figure 7 is a template generation circuit according to the present invention, which achieves the piecewise linear approximation of an exponential decay illustrated in Figure 6.
- FIG 8 is a timing diagram illustrating the operation ofthe slow gain control circuit of Figure 5, in combination with the fast templating generation circuit of Figure 7 in adjusting the gain and the sensing threshold of the cardioverter/defibrillator according to the present invention.
- Cardioverter/defibrillator 20 operates as a pulse generator device portion ofa cardiac rhythm management system which also includes leads or electrodes (not shown) disposed in the ventricular chamber ofthe heart to sense electrical activity representative of a R-wave portion ofthe PQRST complex ofa surface EGM indicating depolarizations in the ventricle.
- Cardioverter/defibrillator 20 includes input/output terminals 22 which are connectable to the ventricular leads to receive the ventricular electrical activity ofthe heart sensed by the ventricular leads.
- a pace pulse circuit 24 provides pacing pulses such as bradycardia and antitachycardia pacing pulses to input/output terminals 22 to be provided to the ventricular chamber ofthe heart via the ventricular leads to stimulate excitable myocardial tissue to treat arrhythmia conditions such as bradycardia and some tachycardia.
- a shock pulse circuit 26 provides shock pulses to input/output terminals 22 to be provided to the ventricular chamber of the heart via the ventricular leads to shock excitable myocardial tissue to treat tachyrhythmia conditions.
- the tachyrhythmia conditions may include either ventricle fibrillation or ventricle tachycardia.
- a filter and after potential removal circuit 28 filters the ventricular electrical activity received by input/output terminals 22 and the pacing pulses provided from pacing pulse circuit 24.
- filter and after potential removal circuit 28 removes after potential created by a pacing pulse from pacing pulse circuit 24 or a shock pulse delivered by shock pulse circuit 26.
- a preferred after potential removal circuit is described in detail in the co-pending and commonly assigned U.S. patent application Serial No. 08/492,199 entitled “AFTER POTENTIAL REMOVAL IN CARDIAC RHYTHM MANAGEMENT DEVICE” filed on June 19, 1995.
- An automatic gain control (AGC)/filter and digitizing circuit 30 amplifies the filtered ventricular electrical activity provided from the filter and after potential removal circuit 28.
- AGC/filter and digitizing circuit 30 includes circuitry for digitizing the filtered ventricular electrical activity.
- a gain control circuit 32 automatically adjusts the gain of AGC/filter and digitizing circuit 30.
- An R-wave detection circuit 34 is coupled to AGC/filter and digitizing circuit 30 to detect depolarizations in the amplified ventricular electrical activity representative of R-wave depolarizations when the amplified ventricular electrical activity exceeds a selected amplified level known as the "sensitivity threshold" or the "sensing threshold” and refractory is inactive.
- a template generation circuit 36 automatically selects and adjusts the sensing threshold.
- R-wave detection circuit 34 provides a R-wave depolarization signal, indicative ofthe R-wave depolarizations, to a microprocessor and memory 38.
- the cardiac rhythm management system also includes leads or electrodes (not shown) disposed in the atrial chamber ofthe heart to sense electrical activity representative ofa P-wave portion ofthe PQRST complex ofa surface EGM indicating depolarizations in the atrium.
- Cardioverter/defibrillator 20 correspondingly also includes input/output terminals 42 which are connectable to the atrial leads to receive the atrial electrical activity ofthe heart sensed by the atrial leads.
- a pace pulse circuit 44 provides pacing pulses such as bradycardia pacing pulses to input/output terminals 42 to be provided to the atrial chamber ofthe heart via the atrial leads to stimulate excitable myocardial tissue to treat arrhythmia conditions such as bradycardia or atrial tachycardia.
- a filter and after potential removal circuit 48 operates similar to filter and after potential removal circuit 28 to filter the atrial electrical activity received by input/output terminals 42 and the pacing pulses provided from pacing pulse circuit 44. In addition, filter and after potential removal circuit 48 removes after potential created by a pacing pulse from pacing pulse circuit 44.
- An automatic gain control (AGC)/filter and digitizing circuit 50 amplifies the filtered atrial electrical activity provided from the filter and after potential removal circuit 48.
- AGC/filter and digitizing circuit 50 includes circuitry for digitizing the filtered atrial electrical activity.
- a gain control circuit 52 automatically adjusts the gain of AGC/filter and digitizing circuit 50.
- An P-wave detection circuit 54 is coupled to AGC/filter and digitizing circuit 50 to detect depolarizations in the amplified atrial electrical activity representative of P-wave depolarizations when the amplified atrial electrical activity exceeds a selected amplified level known as the "sensitivity threshold" or the "sensing threshold” and the refractory is inactive.
- a template generation circuit 56 automatically selects and adjusts the sensing threshold.
- P-wave detection circuit 54 provides a P-wave depolarization signal, indicative ofthe P-wave depolarizations, to microprocessor and memory 38.
- Microprocessor and memory 38 analyzes the detected P-waves indicated in the P-wave depolarization signal from P-wave detection circuit 54 along with the R-wave depolarization signal provided from R-wave detection circuit 34 for the detection of arrhythmia conditions based on known algorithms. For example, microprocessor and memory 38 can be used to analyze the rate, regularity, and onset of variations in the rate ofthe reoccurrence ofthe detected P-wave and/or R-wave, the morphology ofthe detected P-wave and/or R-wave, or the direction of propagation ofthe depolarization represented by the detected P-wave and/or R-wave in the heart.
- microprocessor and memory 38 stores depolarization data and uses known techniques for analysis ofthe detected R-waves to control pace pulse circuit 24 and shock pulse circuit 26 for delivery of pace pulses and shock pulses to the ventricle and for analysis of detected P- waves to control pace pulse circuit 44 for proper delivery of pace pulses to the atrium.
- microprocessor and memory 38 controls a state machine 39 which places various circuits of cardioverter/defibrillator 20 in desired logical states based on various conditions such as when a pace pulse or shock pulse occurs or on operating conditions ofthe cardioverter/defibrillator such as bradycardia pacing, tachyrhythmia sensing, and normal sinus sensing.
- the dual chamber cardioverter/defibrillator 20 with pacing capability illustrated in Figure 1 includes pacing and shocking capabilities for the ventricle and pacing capability for the atrium. Nevertheless, the present invention can be embodied in a single chamber cardiac rhythm management device having a single one of these capabilities. For example, the present invention can be embodied in a ventricle defibrillator device for providing shock pulses to the ventricle only.
- input/output terminals 22 and 42 are each implemented to be connectable to a corresponding single set of electrodes (not shown) used for pacing, shock delivery, and sensing.
- the input/output terminals are implemented to be connectable to separate sets of electrodes for pulse delivery and sensing.
- the input/output terminals are implemented to be connectable to separate electrodes for pacing and shock delivery.
- the electrodes ofa cardiac rhythm management system are typically implemented as unipolar or bipolar electrodes.
- a unipolar electrode configuration has one pole or electrode (i.e., negative pole or cathode electrode) located on or within the heart, and the other pole or electrode (i.e., positive pole or anode electrode) remotely located from the heart.
- the cathode is located at the distal end ofa lead and typically in direct contact with the endocardial tissue to be stimulated, thus forming a "tip" electrode.
- the anode is remotely located from the heart, such as comprising a portion ofthe metallic enclosure which surrounds the implanted device, thus forming a "can" electrode and is often referred to as the "indifferent" electrode.
- a bipolar electrode configuration has both poles or electrodes typically located within the atrial or ventricular chamber ofthe heart. With endocardial leads, for example, the cathode is located at the distal end ofthe lead, referred to as the "tip" electrode. In the bipolar configuration, the anode is usually located approximate to the "tip" electrode spaced apart by 0.5 to 2.5 cm., and typically forming a ring-like structure, referred to as the "ring" electrode.
- bipolar and unipolar electrode configurations do not yield equivalent cardiac EGMs.
- Each configuration has advantages and disadvantages, for example, with a unipolar- sensing configuration, only the electrical events adjacent to the "tip" electrode control the unipolar EGM, while the remote "indifferent" electrode contributes negligible voltage due to its location being extracardiac.
- bipolar-sensing configuration With a bipolar-sensing configuration, the magnitude ofthe cardiac signal is similar for both the "ring” and the “tip” electrodes, but the resulting EGM is highly dependent upon the orientation ofthe electrodes within the heart. Optimal sensing will occur, for example, when the sensing vector defined by the sensing electrodes is parallel with the dipole defined by the depolarization signal. Since bipolar electrodes are more closely spaced than their unipolar counterparts, the depolarization signal will be shorter in duration than that produced from a unipolar configuration. Due to a more restrictive lead field or antenna, bipolar sensing offers improved rejection of electromagnetic and skeletal muscle artifacts, and thus provides a better signal-to-noise ratio than unipolar sensing.
- a logical block diagram representative of AGC/filter and digitizing circuit 30 or 50 is illustrated in Figure 2.
- a programmable gain filter 60 filters the electrical activity provided from the filter and after potential removal circuit 28 or 48 of Figure 1.
- programmable gain filter 60 comprises an analog differential sense amplifier to sense and amplify the difference between first and second bipolar electrodes.
- Programmable gain filter 60 has a programmable gain to initially amplify the incoming electrical activity.
- An analog to digital (A/D) converter 62 receives the filtered and amplified electrical activity from programmable gain filter 60 and converts the analog electrical activity to digitized cardiac data, which is stored in a successive approximation register (SAR) 64.
- A/D converter 62 operates by comparing a sample of "unknown" analog electrical activity from programmable gain filter 60 against a group of weighted values provided from SAR 64 on lines 66.
- a D converter 62 compares the weighted values on lines 66 in descending order, starting with the largest weighted value.
- a weighted value is not added to the summed digital data stored in SAR 64 if the weighted value, when added to the previous summed weighted values, produces a sum larger than the sampled "unknown" analog electrical activity.
- the summed digital data is updated in SAR 64 and a new weighted value is compared on each active edge ofa SAR clock on a line 68.
- the sum ofthe weighted values stored as the summed digital data in SAR 64 represents the approximated value ofthe sampled "unknown"analog electrical activity.
- SAR 64 provides the stored digital cardiac data to an absolute value circuit 70.
- Absolute value circuit 70 provides the absolute value ofthe amplitude ofthe digital cardiac data on a line 72 to be provided to gain control circuit 32/52 and template generation circuit 36/56. Successive approximation A D conversion as performed by A/D converter 62 and SAR 64 is very fast to permit adequate tracking ofthe incoming analog cardiac signal.
- the gain of programmable gain filter 60 is raised or lowered in discrete gain steps based on outputs from gain control circuit 32/52.
- Gain control circuit 32/52 and template generation circuit 36/56 operate with the AGC/filter and digitizing circuit 30/50 to implement two independent AGC digital loops according to the present invention.
- Gain control circuit 32/52 provides slow gain control to AGC/filter and digitizing circuit 30/50 to keep sensed depolarizations representative of cardiac events in approximately the upper one third ofthe dynamic range of A/D converter 62.
- Template generation circuit 36/56 provides a fast responding variable sensing threshold to the detection circuit 34/54 for actual sensing of R-wave or P-wave depolarizations representative of cardiac events.
- Gain control circuit 32/52 stores peak history information representative of peak values ofthe amplified electrical activity ofa selected number (N) of cardiac events. Gain control circuit 32/52 adjusts the variable gain of AGC/filter and digitizing circuit 30/50 in discrete steps based on the stored peak history information. The stored peak history information is compared against predefined levels and appropriate gain changes are initiated based on a second selected number (M) of peak values ofthe N cardiac events being outside of a selected range.
- Template generation circuit 36/56 provides a time varying sensing threshold to detect circuit 34/54 for comparison to the digitized cardiac data provided on line 72 from AGC/filter and digitizing circuit 30/50.
- Detection circuit 34/54 provides a detection signal indicating R-wave or P-wave depolarizations representative of cardiac events when the value ofthe incoming digital cardiac data is greater than the sensing threshold level provided that the refractory windows are inactive.
- Template generation circuit 36/56 includes circuitry for selecting and adjusting the variable sensing threshold to a level proportional to the amplitude ofthe digital cardiac data on line 72. Typically, template generation circuit 36/56 responds very quickly to change the sensing threshold to the peak value ofthe digital cardiac data on line 72. The variable sensing threshold is held at the peak value for a selected period of time after which the variable sensing threshold drops to a percentage ofthe peak value.
- variable sensing threshold is then allowed to slowly decay from this percentage of peak value in discrete steps until the variable sensing threshold is at a low threshold value.
- Template generation circuit 36/56 preferably employs integer math to achieve a piecewise linear approximation ofa geometric progression such as an exponential decay curve with minimal error between piecewise steps. Refractory Periods
- Cardioverter/defibrillator 20 utilizes ventricular and atrial refractory periods to determine which sensed events are R-waves or P-waves respectively.
- the active sensed refractory periods are illustrated in timing diagram form on line 73 at 74 in Figure 3. Any sensed event that occurs when the sensed refractory period is inactive is considered to be a R-wave or P-wave. Any events sensed during the active sensed refractory period are ignored and do not affect the ventricular or atrial cycle length measurement. Typical sensed events occurring on the lead are represented on line 75 at 76. As illustrated, the start ofthe active ventricular or atrial refractory period is synchronized with the start ofthe cardiac cycle.
- An absolute refractory interval is indicated on line 77 at 78.
- the absolute refractory interval starts at the beginning ofthe cardiac cycle simultaneous with the start ofthe active sensed refractory period.
- the absolute refractory interval disables all sensing.
- the operation of template generation circuit 36/56 based on the absolute refractory interval is further described below under the Threshold Templating for a Fast Digital AGC Circuit heading.
- a paced/shock refractory period is utilized instead ofthe sensed refractory period.
- any sensed event that occurs when the paced/shock refractory period is inactive is considered to be a R-wave or P-wave.
- Typical pace pulses on the lead are represented for illustrative purposes on line 83 at 85. A typical shock pulse is not shown.
- the paced/shock refractory period is started with the delivery of the pace or shock pulse. Absolute refractory intervals are not utilized during pacing or shocking conditions.
- the time duration ofthe paced refractory period is preferably programmable, while the time duration ofthe shock refractory period is typically not programmable.
- the paced refractory period can be selected by the physician and programmed into cardioverter/defibrillator 20 when the cardioverter/defibrillator is operating in a pacing mode.
- the operation of template generation circuit 36/56 based on the paced/shock refractory period is further described below under the Threshold Templating for a Fast Digital AGC Circuit heading.
- Gain control circuit 32 or alternately gain control circuit 52, is representatively illustrated in Figure 5 in logical block diagram form.
- a comparator 80 receives the digital cardiac data on line 72 and compares the peak value ofthe digital data representing the current cardiac event to a selected low threshold and a selected high threshold. For example, in one preferred embodiment ofthe present invention where the maximum value ofthe peak value ofthe digital cardiac data is 7F hex, the selected low threshold is 52 hex and the selected high threshold is 7E hex.
- a first storage register 82 includes a first group of storage locations which store peak history information provided by comparator 80 on a line 84 indicative of whether the peak values are below the selected low threshold (52 hex in the example embodiment).
- a second storage register 86 includes a second group of storage locations which store peak history information provided by comparator 80 on a line 88 indicative of whether the peak values are above the selected high threshold (7E hex in the example embodiment).
- An M/N circuit 90 receives peak history information from storage register 82 and determines if M peak values of N cardiac events are below the selected low threshold (52 hex). M/N circuit 90 provides an increment signal on a line 92 to a gain control clock circuit 94. M/N circuit 90 activates the increment signal on line 92 when M out of N peak values are below the selected low threshold (52 hex) to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be incremented by at least one discrete gain step. In one embodiment ofthe present invention, the discrete gain step is approximately equal to 1.25.
- An M/N circuit 96 receives peak history information from storage register 86 and determines if M peak values of N cardiac events are above the selected high threshold (7E hex).
- M/N circuit 96 provides a decrement signal on a line 98 to gain control clock circuit 94.
- M/N circuit 96 activates the decrement signal on line 98 when M out of N peak values are above the selected high threshold (7E hex) to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step.
- the decrementing discrete gain step is preferably equal to the incrementing discrete gain step and is approximately equal to 1.25 in one embodiment ofthe present invention.
- Gain control clock circuit 94 provides a gain control signal on a line 100 which controls the gain of AGC/filter and digitizing circuit 30/50 by causing the gain to be incremented or decremented in discrete gain steps based on the increment signal on line 92 and the decrement signal on line 98.
- the gain of AGC/filter and digitizing circuit 30/50 can be increased or decreased by a fixed number of steps or amount, or the level ofthe discrete gain step is optionally made programmable via microprocessor and memory 38.
- gain control and clock circuit 94 optionally causes increments or decrements of gain in multiple discrete gain steps.
- Gain control circuit 32/52 preferably keeps the peak values of atrial or ventricle sensed cardiac events in approximately the upper one third ofthe dynamic range of A/D converter 62. As a result, the lower approximately two thirds ofthe dynamic range of A/D converter 62 is available for sensing low amplitude signals such as occurring during fibrillation.
- M is equal to three and N is equal to four.
- storage register 82 stores peak history information for four cardiac events in four corresponding storage locations each representative of whether the corresponding one ofthe last four values for peak values was below the selected low threshold (52 hex).
- storage register 86 stores peak history information for four cardiac events in four corresponding storage locations each representative of whether the corresponding one ofthe last four values for peak values was above the selected high threshold (7E hex).
- the peak values in storage register 82 and storage register 86 are preferably updated at the beginning of a new refractory period for a previous sensed event. As new peak value information is acquired from comparator 80, the old peak history information is shifted one value to the right. If storage registers 82 and 86 only contain four storage locations, the peak history values older than the last four cardiac events are shifted out ofthe registers to the right and lost.
- M/N circuit 90 activates the increment signal on line 92 only if the stored peak value ofthe last cardiac event and M - l peak values ofthe last N - l cardiac events previous to the last cardiac event are below the selected low threshold (52 hex).
- M/N circuit 96 activates the decrement signal on line 98 only if the stored peak value ofthe last cardiac event and M - l peak values ofthe last N - l cardiac events previous to the last cardiac event are above the selected high threshold (7E hex).
- Gain control circuit 32/52 operates as described above to minimize the possibility of improper sensing by not allowing AGC/filter and digitizing circuit 30/50 to go to low sensitivity if large R-waves or P-waves are present or to go to full sensitivity in the presence of slow R-waves or P-waves. Improper sensing can cause therapy to be delivered to a patient at inappropriate times as a result of false indications of a ⁇ hythmia conditions. Oversensing is reduced because the full sensitivity of AGC/filter and digitizing circuit 30/50 is not reached between slow beats as a result of gain control circuit 32/52 keeping the amplified depolarization electrical activity in the upper approximately one third ofthe dynamic range of A D converter 62.
- the reduced oversensing greatly increases the comfort level of a patient having the cardioverter/defibrillator according to the present invention implanted in his or her body. Undersensing is reduced because minimum sensitivity will not occur due to a single large R-wave or P-wave.
- gain control circuit 32/52 eliminates the need for a high precision A/D converter implementation of A/D converter 62, because the entire dynamic range ofthe incoming cardiac signal does not need to be spanned.
- A/D converter 62 is implemented in 8 bits or less.
- the dynamic range ofthe incoming cardiac signal from the atrial and/or ventricular channels ofthe heart ranges from 0J mV to 25 mV representing a 250 to 1 dynamic range.
- Lower precision A/D converters consume less power, convert the incoming analog signal to representative digital data more quickly, and allow more cost effective silicon processes to be utilized.
- the preferred embodiment of gain control circuit 32/52 illustrated in Figure 5 includes a far field sense circuit 102.
- Far field sense circuit 102 provides a solution to a possible AGC loop lock-up due to far field sensing. For example, when sensing events in the ventricle channel ofthe heart, P-waves, representing far field events, can be sensed during normal sinus rhythms at maximum sensitivity. Under this example condition, instead of AGCing on the R-wave peaks, which are clipped, the P-wave peak level alternating with the clipped R-wave peak level combine to inhibit gain changes. The clipped R-wave peaks indicate that the R-wave peaks are above the maximum digital value for a peak signal.
- Far field sense circuit 102 responds to the last N + 2 sensed events stored in storage register 86 to determine if the storage information alternates between clipped peaks and non-clipped peaks for the last N + 2 sensed events. Far field sense circuit 102 determines that a peak is clipped when the peak is at the maximum value (7F hex) which corresponds to peak values greater than the high threshold value used by comparator 80 (7E hex). Far field sense circuit 102 provides a decrement signal on a line 104 to gain control clock circuit 94.
- Far field sense circuit 102 activates the decrement signal on line 104 when the peak history information in storage register 86 alternates between clipped peaks and non-clipped peaks for the last N + 2 sensed events.
- the decrement signal on line 104 indicates that gain of AGC/filter and digitizing circuit 30/50 is to be decremented by one discrete gain step, but can alternatively indicate any number of discrete gain step changes.
- Far field sense circuit 102 operates in the cases where the actual depolarization ofthe incoming cardiac signal is clipped to prevent the digital AGC loop from locking up under the condition of far field sensed events. If far field events are detected in the above manner, the gain of AGC/filter and digitizing circuit 30/50 is decreased to the point that far field events no longer are sensed.
- the far field sense circuit 102 greatly improves sensing discrimination by minimizing or substantially eliminating oversensing in the presence of far field events. Accordingly, the cardioverter/defibrillator according to the present invention provides a patient and his or her physician a cardioverter/defibrillator which senses the R-wave depolarizations more reliably. Slow Gain Jump Back for AGC
- Previous gain circuitry reaches maximum sensitivity in a single cardiac cycle. Unlike previous gain circuitry, the slow gain circuitry according to the present invention described above makes discrete step gain changes of one or more discrete gain step per cardiac depolarization cycle, so that full sensitivity ofthe AGC/filter and digitizing circuit 30/50 is not reached between cardiac depolarizations, which can cause undersensing of cardiac events. As illustrated in Figure 5, additional circuitry is preferably added to gain control circuit 32/52 to prevent undersensing of cardiac events.
- Exception circuitry 106 detects any one of three conditions which indicate that the gain ofthe AGC/filter and digitizing circuit 30/50 is to be set to a selected relatively high sensitivity. Exception circuitry 106 provides a set gain signal on a line 108 to cause the gain of AGC/filter and digitizing circuit 30/50 to be set to the selected relatively high sensitivity when any ofthe three conditions occur.
- the first condition occurs when a cardiac event is not detected for a selected time period (i.e., a R-wave or P-wave depolarization is not sensed for the selected time period). Typically, the selected time period is equal to approximately 1.5 seconds, co ⁇ esponding to a heart rate of less than 40 beats per minute.
- the second condition occurs after the cardioverter/defibrillator delivers a shock pulse.
- the third condition occurs after the cardioverter/defibrillator delivers a pacing pulse.
- A/D converter 62 typically operates in bands of an approximately 10:1 dynamic range.
- the combined 10:1 dynamic range bands create a total 250:1 dynamic range of A/D converter 62.
- the three exception conditions are conditions where A/D converter 62 needs to operate near maximum sensitivity, or in other words, near the upper portion of the highest 10:1 dynamic range band to adequately prevent undersensing.
- the selected relatively high sensitivity is two gain steps from a maximum sensitivity to prevent mistaking P-wave depolarizations and T-wave repolarizations for R- wave depolarizations. If the selected relatively high sensitivity creates a clipped signal on the following depolarization, having its peak at the maximum value (7F hex), as indicated from comparator 80 on line 88, a jump back compare circuit 110 activates a line 114 to a two input OR gate 116 to indicate that the gain is to be reduced by an offset value stored in offset register 112.
- OR gate 116 provides a decrement signal on an enable line 120 to gain control clock circuit 94 which is activated when either ofthe two inputs to the OR gate are activated to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step during the cu ⁇ ent refractory period.
- the offset value stored in register 112 is preferably programmable and is provided to gain control clock circuit 94. In one embodiment, the offset value is programmed to equal three discrete gain steps.
- comparator 80 indicates on line 88 that the peak ofthe cardiac signal is still clipped.
- Jump back compare circuit 110 indicates that the gain is to be decremented by at least one discrete gain step by activating a line 118 to the other input of OR gate 116, which co ⁇ espondingly activates enable line 120 to gain control clock circuit 94. If the peak value is still clipped, normal AGC action as described above resumes. This two staged back off mechanism after a jump out or escape to the selected relatively high sensitivity due to lack of sensing reduces oversensing resulting from the clipped peak ofthe cardiac signal.
- jump back compare circuit 110 activates line 114 to two input OR gate 116 to indicate that the gain is to be reduced by the offset value stored in offset register 112.
- OR gate 116 provides the decrement signal on enable line 120 to gain control clock circuit 94 which is activated when either ofthe two inputs to the OR gate are activated to indicate that the gain of AGC/filter and digitizing circuit 30/50 is to be decremented by at least one discrete gain step during the cu ⁇ ent refractory period. If the peak value is still clipped, normal AGC action as described above resumes. This situation, where the peak value ofthe first detected depolarization is not clipped and the peak value ofthe second detected depolarization is clipped after the gain is set to the relatively high sensitivity, results when the first depolarization represents a far field sensed event such as described above. For example, when sensing events in the ventricle channel ofthe heart, P-waves, representing far field events, can be sensed during normal sinus rhythms at maximum sensitivity.
- Figure 6 illustrates, in timing diagram form, the variable sensing threshold generated by template generation circuit 36/56 and provided to detection circuit 34/54.
- the variable sensing threshold is indicated by line 130.
- the variable sensing threshold 130 follows a piecewise linear approximation of an exponential decay curve with minimal e ⁇ or between steps.
- the template generation circuit 36/56 forces the variable sensing threshold 130 to rapidly follow the maximum peak level ofthe digitized cardiac data.
- template generation circuit 36/56 raises the variable sensing threshold 130 to a peak threshold value approximately equal to the peak value ofthe incoming digitized cardiac data as indicated at time T(0).
- template generation circuit 36/56 sets the variable sensing threshold 130 to a selected relatively high threshold value.
- the selected relatively high threshold value is preferably 7E hex in the example embodiment or one binary number below the maximum value of the variable threshold.
- the variable sensing threshold 130 remains at the peak threshold value through a refractory or a portion of a refractory period indicated at 132.
- the period indicated at 132 is a programmed paced refractory period that is selected by the physician and programmed into the cardioverter/defibrillator, such as the paced/shock refractory period indicated at 81 is Figure 4.
- the cardioverter/defibrillator is operating in shocking mode, the period indicated at 132 is a shock refractory period, such as the paced refractory period indicated at 81 is Figure 4.
- the period indicated at 132 is a portion ofa sensed refractory period, such as the absolute refractory period indicated at 78 is Figure 4.
- the variable sensing threshold does not begin to decay from the peak threshold value attained at time T(0) for an additional drop time indicated at 134.
- the drop time is a normal template hold time for the peak converter circuitry of template generation circuit 36/56, and is empirically determined.
- a suitable value for the drop time in one embodiment ofthe present invention is approximately 13.7 msec.
- the variable sensing threshold 130 drops by an initial drop percentage, indicated by anows 136.
- the initial drop percentage is preferably approximately 25% ofthe peak threshold value so that the level ofthe variable sensing threshold obtained at time T(1,0) is approximately 75% ofthe initial peak threshold value.
- the variable sensing threshold starts to decay in discrete steps such as indicated at 138.
- the step time size is representatively indicated by arrows 140 between time T( 1 , 1 ) and T( 1 ,2) .
- the level ofthe variable sensing threshold 130 decays from a percentage ofthe peak threshold value to step over wide depolarizations or T-waves in the incoming electrical activity.
- template generation circuit 36/56 drops the variable sensing threshold 130 in step groups comprising multiple discrete steps.
- the step group size is four.
- Each step group decreases the variable sensing threshold by a defined percentage, as indicated by anows 142 for a four step group between time T(1,0) and T(2,0), anows 144 for a four step group between T(2,0) and T(3,0), and anows 146 for a four step group between T(3,0) and T(4,0).
- the defined percentage for each step group is preferably approximately 50%.
- the value ofthe variable sensing threshold at time T(2,0) is approximately 50% of the value ofthe variable sensing threshold at time T(1,0)
- the value ofthe variable sensing threshold at time T(3,0) is approximately 50% ofthe value of the variable sensing threshold at time T(2,0) or 25% ofthe value ofthe variable sensing threshold at time T(1,0).
- variable sensing threshold 130 decays to a programmable final value, as indicated at 148, template generation circuit 36/56 holds the variable sensing threshold at the programmable final value until a new sensed event occurs.
- the programmable final value is programmable to compensate for noise which is inherent in the sense amplifiers and other AGC system circuits ofthe AGC loop.
- the initial drop percentage to achieve approximately 75% ofthe peak threshold value, and the four discrete steps in each step group to drop the variable sensing threshold to approximately 50% ofthe level ofthe start ofthe four-step group realizes a piecewise geometric progression linear approximation representing an exponential decay curve with minimal enor between piecewise steps. Since the sensing threshold drops in discrete steps as indicated at 138, integer math can be utilized in template generation circuit 36/56. For example in the embodiment of template generation circuit 36/56 illustrated in Figure 6, floating point numbers are not required because the maximum difference/e ⁇ or between any two discrete steps in a four step group is one bit. The present invention can be extended to use any size integer value or number of steps or step groups to achieve the linear approximation ofthe exponential decay curve.
- TEMP T(X,0) - T(X,0) 12 + T(X,0) /8
- TEMP is calculated to 75% ofthe initial peak threshold value, and TEMPI is calculated to 50% of a previous step group value. If the step group is the first drop from the peak threshold value, then T(1,0) is equal to TEMP or 75% ofthe peak value. In successive drops, T(X,0) is equal to TEMPI or a 50% drop from the level at the beginning ofthe previous step group.
- the variable sensing threshold obtains the TEMP value unless the TEMP value is less than FINAL THRESHOLD which is the final programmable value indicated at 148 in Figure 6.
- T(XJ) is set to TEMP which is calculated to 87.5% ofthe T(X,0) value.
- T(X,2) is set to TEMP which is calculated to 75% ofthe T(X,0) value.
- T(X,3) is set to TEMP which is calculated to 62.5% ofthe T(X,0) value.
- a peak detection circuit 160 detects the peak value ofthe digitized cardiac data provided on line 72 from AGC/filter and digitizing circuit 30/50. Peak detection circuit 160 provides a peak threshold value which is equal to the peak value ofthe digitized data to a threshold register 162 ifthe digitized peak is greater than the cunent threshold value. Threshold register 162 stores and provides the cunent variable sensing threshold on line 164 to the detection circuit 34/54. Peak detection circuit 160 also provides the peak threshold value to T(X,0) register 166.
- the TEMPI calculation must be implemented for the T(X,0) interval ofthe discrete step calculation algorithm in TABLE I above.
- the T(X-1,0) value stored in the T(X,0) register 166 from the previous step group is divided by 2 through a hard shift of one to the right as indicated by line 168 to place the shifted data in both the threshold register 162 and the T(X,0) register 166.
- T(X,0) register 166 provides its cu ⁇ ently stored value to a subtraction circuit 170 and a shifter 172.
- Shifter 172 provides either a divide by 2 or a divide by 4 calculation by shifting the cu ⁇ ent T(X,0) value by one bit or two bits to the right, respectively.
- Subtractor 170 subtracts the value stored in the T(X,0) register 166 from a shifted output provided from shifter 172.
- the shifted output of shifter 162 is also provided to a shifter 174.
- Shifter 174 provides an additional divide by 2 or divide by 4 through shifts of 1 bit or 2 bits to the right, respectively.
- a difference output of subtractor 170 is provided to an adder 176.
- a shifted output of shifter 174 is provided to the other input of adder 176.
- Adder 176 adds the difference output of subtractor 170 and the shifted output of shifter 174 and provides the added value to threshold register 162.
- the shifters 172 and 174 can, in combination, achieve shifts of 1, 2, 3, or 4 bits to produce divide by 2, divide by 4, divide by 8, or divide by 16 calculations.
- the TEMP calculations required for the T(X,0), T(XJ), T(X,2), and T(X,3) intervals ofthe discrete step calculation algorithm in TABLE I above are all achieved through shifters 172 and 174 in combination with subtractor 170 and adder 176.
- Shifters 172 and 174 calculate the desired divide by values which are then properly combined according to the algorithm in TABLE I with subtractor 170 and adder 176.
- a final threshold register 178 stores the programmable final value, indicated at 148 in Figure 6, ofthe variable sensing threshold.
- the programmable final value is provided to a threshold comparator 180.
- Threshold comparator 180 compares the programmable final value stored in final threshold register 178 with the cunent variable sensing threshold value on line 164. Threshold comparator 180 indicates to threshold register 162, on a line 182, whether the cunent variable sensing threshold value is greater than the programmable final value. Ifthe programmable final value is greater than the calculated sensing threshold value, then the final value is stored in threshold register 162. The sensing threshold value stays at the final value until the incoming digitized cardiac data exceeds the final value indicating a new sensed event. In fact, a new sensed event occurs any time the incoming digitized cardiac data peak value exceeds the cu ⁇ ent variable sensing threshold value on line 164.
- the variable sensing threshold obtains a new T(0) peak threshold value equal to the peak value ofthe sensed depolarization in the digitized cardiac data.
- the above described threshold templating algorithm for a fast digital AGC system is completely contained in digital logic as implemented in the prefened embodiment.
- the digital logic implementation is easily characterized, tested, and achieves repeatable results.
- external parts are eliminated from the silicon chip implementation ofthe AGC circuitry to reduce cost and increase the manufacturability ofthe AGC silicon chip.
- Testing and characterization ofthe cardioverter/defibrillator devices is uniform from one device to another. In this way, it is easier for the physician to determine how to implement the cardioverter/defibrillator device in a patient, because the device reacts consistently from one unit to another.
- the step time size indicated by anows 140 in Figure 6 is programmable to achieve a tailorable AGC decay rate for the variable sensing threshold 130. In this way, by varying the step time size 140 for each ofthe defibrillator's operating conditions, the decay rate is customized to optimally meet the selected operating condition.
- a single attack rate is utilized that covers most ofthe incoming cardiac signals.
- the step time size 140 is set to 29.3 mSec/step to achieve the normal sinus sensing decay rate.
- Tachyrhythmia sensing is a special condition under which a fast response rate is desirable in order to properly track the higher tachyrhythmia rates, such as during fibrillation or tachycardia. This is especially true in the atrium ofthe heart, where tachyrhythmia rates run in excess of 300 beats per minute.
- step size 140 is set to approximately 17.5 mSec/step for atrial tachyrhythmia conditions, and is set to approximately 23.5 mSec/step for ventricle tachyrhythmia conditions.
- Bradycardia pacing is a special operating condition wherein the decay rate ofthe sensing threshold is tied to the bradycardia pacing rate to help minimize oversensing and undersensing conditions.
- the sensing template attack rate is fixed.
- the cardioverter/defibrillator with pacing capability utilizing AGC according to the present invention does not have time to decay to maximum sensitivity. Ifthe decay rate is not sufficiently sped up along with the high pacing rates undersensing occurs and the cardioverter/defibrillator continues pacing in the presence of fibrillation.
- the decay rate is sufficiently sped up to enable the cardioverter/defibrillator according to the present invention to sense and properly respond to the fibrillation condition.
- a longer decay rate is desirable to minimize the possibility of oversensing.
- the formula for calculating the post pace template step time size 140 for bradycardia pacing conditions is as follows:
- DROP TIME normal template hold time for peak converter (approximately 13.7 mSec in a prefened embodiment)
- MINIMUM TIME minimum time allowed for template at final value (approximately 100 mSec in a prefened embodiment)
- X number of steps to go from seed value to final value (equal to 12 steps in the embodiment illustrated in Figure 6)
- the cycle length is equal to the pacing cycle length or from time T(0) to T(0) between each pacing pulse.
- the paced refractory period is indicated by anows 132.
- the drop time is indicated by anows 134.
- the time the variable sensing threshold is at the programmable final value before the next pacing pulse is indicated by anows 150. Since multiple pacing rates are assigned the same step size, the time indicated at 150 varies from approximately 100 mSec to 200 mSec in the embodiment illustrated.
- the minimum time is the minimum time allowed for the time indicated by anows 150, or approximately 100 mSec.
- X represents the 12 steps (i.e., the 3 X four step groups) to go from the peak sensing value at time T(0) to the programmed final value ofthe variable sensing threshold achieved at T(4,0).
- a look-up table stored in microprocessor and memory 38 is formed by dividing the cycle length by 64, which results in a shift of six bits to the right.
- the cycle length is equal to 12 bits, which results in six bits being shifted off in the divide by 64 formation ofthe look-up table in microprocessor and memory 38, resulting in 64 entries in the look-up table.
- the cunent cycle length is divided by 64 to index the look-up table to access the values stored in the look-up table conesponding to the above step time size fo ⁇ nula.
- the digital embodiment ofthe AGC loop as described above allows the above described firmware implemented in the look-up table in the microprocessor and memory 38 to dynamically adjust the sensing characteristics ofthe cardioverter/defibrillator according to the present invention.
- the tailorable AGC decay rate according to the present invention can be utilized to orthogonally optimize sensing characteristics of bradycardia and tachyrhythmia signals, which have mutually exclusive sensing requirements. In this way, the physician controls a better- behaved cardioverter/defibrillator.
- patient comfort is increased, due to reducing oversensing and undersensing of treatable a ⁇ hythmia conditions in the patient. Interaction of Digital AGC Using Separate Gain Control and Threshold Templating
- Figure 8 illustrates in timing diagram form depolarization cycles in the electrical activity ofthe heart.
- the incoming electrical activity at input/output terminals 22 or 42 is indicated by waveform 200.
- the filtered and gain controlled digitized cardiac signal is indicated by waveform 202.
- the variable sensing threshold is indicated by waveform 204.
- the absolute value of the digitized and gain controlled cardiac signal is indicated by waveform 206 underneath the variable sensing threshold waveform 204.
- the refractory period is indicated by waveform 208.
- the discrete stepped slow gain is indicated by waveform 210.
- variable sensing threshold waveform responds to the absolute value ofthe digitized cardiac signal to assume the peak value ofthe digitized cardiac signal.
- the variable sensing threshold then decays according to a piecewise linear approximation of an exponential decay curve to step over wide depolarizations or T-waves.
- the influence ofthe slow gain control on the fast templating circuit is illustrated at time 212.
- the gain is decreased at time 212, which conespondingly results in a reduced filtered and gain controlled digitized cardiac signal indicated at 202, which conespondingly reduces the variable sensing threshold indicated at 204 as the variable sensing threshold follows the peak value ofthe absolute value ofthe digitized and gain controlled cardiac signal indicated at 206.
- the AGC response is effectively moved from analog circuits into the digital logic circuits, where it is easier to test and characterize.
- Design ofthe sense amplifier is simplified, due to the digital control ofthe sense amplifier. It is easier to test and characterize the analog sense amplifier, since the AGC circuitry is no longer in the analog domain.
- the cardioverter/defibrillator device is more uniform from device to device, which greatly increases the physician's ease of predicting device behavior. In addition, the patient comfort is increased due to reduced oversensing and undersensing.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96928864A EP0844898A1 (en) | 1995-08-14 | 1996-08-14 | Threshold templating for digital agc |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/514,929 | 1995-08-14 | ||
US08/514,929 US5658317A (en) | 1995-08-14 | 1995-08-14 | Threshold templating for digital AGC |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997006851A1 true WO1997006851A1 (en) | 1997-02-27 |
Family
ID=24049272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/013181 WO1997006851A1 (en) | 1995-08-14 | 1996-08-14 | Threshold templating for digital agc |
Country Status (4)
Country | Link |
---|---|
US (1) | US5658317A (en) |
EP (1) | EP0844898A1 (en) |
CA (1) | CA2228578A1 (en) |
WO (1) | WO1997006851A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049451A1 (en) * | 1996-06-26 | 1997-12-31 | Medtronic, Inc. | Gain control for a periodic signal and method regarding same |
EP2510975A1 (en) * | 2011-04-14 | 2012-10-17 | BIOTRONIK SE & Co. KG | Cardiac stimulator |
Families Citing this family (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19626353A1 (en) * | 1996-06-18 | 1998-01-02 | Biotronik Mess & Therapieg | Signal detector |
US5941903A (en) * | 1998-04-30 | 1999-08-24 | Cardiac Pacemakers, Inc | Pacemaker for detection of evoked response |
US6169918B1 (en) | 1998-10-28 | 2001-01-02 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with cross-chamber soft blanking |
US6249701B1 (en) | 1999-02-12 | 2001-06-19 | Medtronic, Inc. | Implantable device with automatic sensing adjustment |
US6304778B1 (en) * | 1999-08-20 | 2001-10-16 | Cardiac Pacemakers, Inc. | Implantable defibrillators with programmable cross-chamber blanking |
US6282446B1 (en) | 1999-08-20 | 2001-08-28 | Cardiac Pacemakers, Inc. | Automatic shock lead gain adjuster |
US6418343B1 (en) * | 1999-10-01 | 2002-07-09 | Cardiac Pacemakers, Inc. | Method and apparatus for adjusting the sensing threshold of a cardiac rhythm management device |
US6876991B1 (en) | 1999-11-08 | 2005-04-05 | Collaborative Decision Platforms, Llc. | System, method and computer program product for a collaborative decision platform |
US7801606B2 (en) | 2000-08-29 | 2010-09-21 | Cardiac Pacemakers, Inc. | Implantable pulse generator and method having adjustable signal blanking |
US7090682B2 (en) | 2000-09-18 | 2006-08-15 | Cameron Health, Inc. | Method and apparatus for extraction of a subcutaneous electrode |
US7069080B2 (en) | 2000-09-18 | 2006-06-27 | Cameron Health, Inc. | Active housing and subcutaneous electrode cardioversion/defibrillating system |
US6950705B2 (en) | 2000-09-18 | 2005-09-27 | Cameron Health, Inc. | Canister designs for implantable cardioverter-defibrillators |
US6954670B2 (en) * | 2001-11-05 | 2005-10-11 | Cameron Health, Inc. | Simplified defibrillator output circuit |
US7149575B2 (en) | 2000-09-18 | 2006-12-12 | Cameron Health, Inc. | Subcutaneous cardiac stimulator device having an anteriorly positioned electrode |
US20020035378A1 (en) * | 2000-09-18 | 2002-03-21 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with highly maneuverable insertion tool |
US7039465B2 (en) | 2000-09-18 | 2006-05-02 | Cameron Health, Inc. | Ceramics and/or other material insulated shell for active and non-active S-ICD can |
US7194309B2 (en) * | 2000-09-18 | 2007-03-20 | Cameron Health, Inc. | Packaging technology for non-transvenous cardioverter/defibrillator devices |
US6937907B2 (en) * | 2000-09-18 | 2005-08-30 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with low-profile installation appendage and method of doing same |
US20020107544A1 (en) * | 2000-09-18 | 2002-08-08 | Cameron Health, Inc. | Current waveform for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
US6788974B2 (en) * | 2000-09-18 | 2004-09-07 | Cameron Health, Inc. | Radian curve shaped implantable cardioverter-defibrillator canister |
US6927721B2 (en) * | 2001-11-05 | 2005-08-09 | Cameron Health, Inc. | Low power A/D converter |
US20020035381A1 (en) * | 2000-09-18 | 2002-03-21 | Cameron Health, Inc. | Subcutaneous electrode with improved contact shape for transthoracic conduction |
US6988003B2 (en) * | 2000-09-18 | 2006-01-17 | Cameron Health, Inc. | Implantable cardioverter-defibrillator having two spaced apart shocking electrodes on housing |
US7076296B2 (en) * | 2000-09-18 | 2006-07-11 | Cameron Health, Inc. | Method of supplying energy to subcutaneous cardioverter-defibrillator and pacer |
US6721597B1 (en) * | 2000-09-18 | 2004-04-13 | Cameron Health, Inc. | Subcutaneous only implantable cardioverter defibrillator and optional pacer |
US6865417B2 (en) * | 2001-11-05 | 2005-03-08 | Cameron Health, Inc. | H-bridge with sensing circuit |
US20020035379A1 (en) | 2000-09-18 | 2002-03-21 | Bardy Gust H. | Subcutaneous electrode for transthoracic conduction with improved installation characteristics |
US7065407B2 (en) | 2000-09-18 | 2006-06-20 | Cameron Health, Inc. | Duckbill-shaped implantable cardioverter-defibrillator canister and method of use |
US20020035377A1 (en) * | 2000-09-18 | 2002-03-21 | Cameron Health, Inc. | Subcutaneous electrode for transthoracic conduction with insertion tool |
US6778860B2 (en) | 2001-11-05 | 2004-08-17 | Cameron Health, Inc. | Switched capacitor defibrillation circuit |
US6856835B2 (en) | 2000-09-18 | 2005-02-15 | Cameron Health, Inc. | Biphasic waveform for anti-tachycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
US7194302B2 (en) | 2000-09-18 | 2007-03-20 | Cameron Health, Inc. | Subcutaneous cardiac stimulator with small contact surface electrodes |
US7092754B2 (en) * | 2000-09-18 | 2006-08-15 | Cameron Health, Inc. | Monophasic waveform for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
US7120495B2 (en) * | 2000-09-18 | 2006-10-10 | Cameron Health, Inc. | Flexible subcutaneous implantable cardioverter-defibrillator |
US7751885B2 (en) * | 2000-09-18 | 2010-07-06 | Cameron Health, Inc. | Bradycardia pacing in a subcutaneous device |
US6952608B2 (en) * | 2001-11-05 | 2005-10-04 | Cameron Health, Inc. | Defibrillation pacing circuitry |
US6754528B2 (en) * | 2001-11-21 | 2004-06-22 | Cameraon Health, Inc. | Apparatus and method of arrhythmia detection in a subcutaneous implantable cardioverter/defibrillator |
US6834204B2 (en) | 2001-11-05 | 2004-12-21 | Cameron Health, Inc. | Method and apparatus for inducing defibrillation in a patient using a T-shock waveform |
US6866044B2 (en) | 2000-09-18 | 2005-03-15 | Cameron Health, Inc. | Method of insertion and implantation of implantable cardioverter-defibrillator canisters |
US7043299B2 (en) | 2000-09-18 | 2006-05-09 | Cameron Health, Inc. | Subcutaneous implantable cardioverter-defibrillator employing a telescoping lead |
US6952610B2 (en) * | 2000-09-18 | 2005-10-04 | Cameron Health, Inc. | Current waveforms for anti-tachycardia pacing for a subcutaneous implantable cardioverter- defibrillator |
US7146212B2 (en) | 2000-09-18 | 2006-12-05 | Cameron Health, Inc. | Anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator |
US6510339B2 (en) | 2000-12-06 | 2003-01-21 | Cardiac Pacemakers, Inc. | ECG auto-gain control |
US7248921B2 (en) | 2003-06-02 | 2007-07-24 | Cameron Health, Inc. | Method and devices for performing cardiac waveform appraisal |
US7330757B2 (en) | 2001-11-21 | 2008-02-12 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
US7392085B2 (en) | 2001-11-21 | 2008-06-24 | Cameron Health, Inc. | Multiple electrode vectors for implantable cardiac treatment devices |
US7027858B2 (en) | 2002-09-11 | 2006-04-11 | Medtronic, Inc. | Methods and apparatus for cardiac R-wave sensing in a subcutaneous ECG waveform |
US6928323B2 (en) * | 2002-12-30 | 2005-08-09 | Cardiac Pacemakers, Inc. | Adaptive sensing threshold for cross-chamber refractory period |
US20040260350A1 (en) * | 2003-06-20 | 2004-12-23 | Medtronic, Inc. | Automatic EGM amplitude measurements during tachyarrhythmia episodes |
EP1684856B1 (en) * | 2003-10-27 | 2007-08-29 | St Jude Medical AB | Device for adjusting the sensitivity level of an implantable medical device |
US7349732B1 (en) | 2003-12-12 | 2008-03-25 | Pacesetter, Inc. | System and method for emulating a surface EKG using internal cardiac signals sensed by an implantable medical device |
US7945314B1 (en) | 2003-12-12 | 2011-05-17 | Pacesetter, Inc. | System and method for emulating a surface EKG for use with transtelephonic monitoring of an implantable medical device |
US7383080B1 (en) | 2003-12-12 | 2008-06-03 | Pacesetter, Inc. | System and method for emulating a surface EKG using internal cardiac signals sensed by an implantable medical device |
US7933643B1 (en) | 2003-12-12 | 2011-04-26 | Pacesetter, Inc. | System and method for displaying an emulated surface EKG using an external programming device |
US7546157B1 (en) | 2003-12-12 | 2009-06-09 | Pacesetter, Inc. | System and method for emulating a surface EKG using internal cardiac signals sensed by an implantable medical device |
KR100601953B1 (en) * | 2004-05-03 | 2006-07-14 | 삼성전자주식회사 | Capacitor of memory device and fabrication method thereof |
US7155275B2 (en) * | 2004-10-18 | 2006-12-26 | Cardiac Pacemakers, Inc. | Method and apparatus for adjusting cardiac event detection threshold based on dynamic noise estimation |
US20060089681A1 (en) * | 2004-10-21 | 2006-04-27 | Cameron Health, Inc. | Implantable medical device |
US7376458B2 (en) * | 2004-11-29 | 2008-05-20 | Cameron Health, Inc. | Method for defining signal templates in implantable cardiac devices |
US7477935B2 (en) * | 2004-11-29 | 2009-01-13 | Cameron Health, Inc. | Method and apparatus for beat alignment and comparison |
US7655014B2 (en) * | 2004-12-06 | 2010-02-02 | Cameron Health, Inc. | Apparatus and method for subcutaneous electrode insertion |
US8160697B2 (en) | 2005-01-25 | 2012-04-17 | Cameron Health, Inc. | Method for adapting charge initiation for an implantable cardioverter-defibrillator |
US8229563B2 (en) | 2005-01-25 | 2012-07-24 | Cameron Health, Inc. | Devices for adapting charge initiation for an implantable cardioverter-defibrillator |
US7555338B2 (en) * | 2005-04-26 | 2009-06-30 | Cameron Health, Inc. | Methods and implantable devices for inducing fibrillation by alternating constant current |
US8116867B2 (en) | 2005-08-04 | 2012-02-14 | Cameron Health, Inc. | Methods and devices for tachyarrhythmia sensing and high-pass filter bypass |
US7756571B1 (en) | 2005-09-16 | 2010-07-13 | Pacesetter, Inc. | Methods and systems for detecting the presence of T-wave alternans |
US7881792B1 (en) | 2005-09-16 | 2011-02-01 | Pacesetter, Inc. | Methods and systems for detecting the presence of T-wave alternans |
US7738956B1 (en) | 2006-01-27 | 2010-06-15 | Pacesetter, Inc. | Pacing schemes for revealing T-wave alternans (TWA) at low to moderate heart rates |
US8200341B2 (en) | 2007-02-07 | 2012-06-12 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
US8788023B2 (en) | 2006-05-26 | 2014-07-22 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device |
US7783340B2 (en) | 2007-01-16 | 2010-08-24 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device using a polynomial approach |
US7623909B2 (en) | 2006-05-26 | 2009-11-24 | Cameron Health, Inc. | Implantable medical devices and programmers adapted for sensing vector selection |
US20080015644A1 (en) * | 2006-07-14 | 2008-01-17 | Cameron Health, Inc. | End of life battery testing in an implantable medical device |
US7623913B2 (en) * | 2006-08-01 | 2009-11-24 | Cameron Health, Inc. | Implantable medical devices using heuristic filtering in cardiac event detection |
US8718793B2 (en) | 2006-08-01 | 2014-05-06 | Cameron Health, Inc. | Electrode insertion tools, lead assemblies, kits and methods for placement of cardiac device electrodes |
US7877139B2 (en) | 2006-09-22 | 2011-01-25 | Cameron Health, Inc. | Method and device for implantable cardiac stimulus device lead impedance measurement |
US8014851B2 (en) | 2006-09-26 | 2011-09-06 | Cameron Health, Inc. | Signal analysis in implantable cardiac treatment devices |
US7623916B2 (en) | 2006-12-20 | 2009-11-24 | Cameron Health, Inc. | Implantable cardiac stimulus devices and methods with input recharge circuitry |
US8340768B2 (en) * | 2007-12-12 | 2012-12-25 | Cardiac Pacemakers, Inc. | Sensing threshold control to limit amplitude tracking |
US8494630B2 (en) | 2008-01-18 | 2013-07-23 | Cameron Health, Inc. | Data manipulation following delivery of a cardiac stimulus in an implantable cardiac stimulus device |
CA2717442C (en) | 2008-03-07 | 2017-11-07 | Cameron Health, Inc. | Accurate cardiac event detection in an implantable cardiac stimulus device |
EP2574371B1 (en) | 2008-03-07 | 2014-06-18 | Cameron Health, Inc. | Devices for accurately classifying cardiac activity |
US8160687B2 (en) | 2008-05-07 | 2012-04-17 | Cameron Health, Inc. | Methods and devices for accurately classifying cardiac activity |
US8712523B2 (en) | 2008-12-12 | 2014-04-29 | Cameron Health Inc. | Implantable defibrillator systems and methods with mitigations for saturation avoidance and accommodation |
JP5702375B2 (en) | 2009-06-29 | 2015-04-15 | キャメロン ヘルス、 インコーポレイテッド | Adaptive confirmation of treatable arrhythmias in implantable cardiac therapy devices |
US8265737B2 (en) * | 2009-10-27 | 2012-09-11 | Cameron Health, Inc. | Methods and devices for identifying overdetection of cardiac signals |
US8744555B2 (en) | 2009-10-27 | 2014-06-03 | Cameron Health, Inc. | Adaptive waveform appraisal in an implantable cardiac system |
US8548573B2 (en) | 2010-01-18 | 2013-10-01 | Cameron Health, Inc. | Dynamically filtered beat detection in an implantable cardiac device |
US9380956B2 (en) | 2011-09-28 | 2016-07-05 | Samsung Electronics Co., Ltd. | Method and apparatus for classifying cardiac arrhythmia |
US9936889B2 (en) * | 2012-03-08 | 2018-04-10 | Samsung Electronics Co., Ltd. | Apparatus and method of controlling threshold for detecting peaks of physiological signals |
EP2967404B1 (en) | 2013-03-11 | 2019-05-22 | Cameron Health, Inc. | Device implementing dual criteria for arrhythmia detection |
US9579065B2 (en) | 2013-03-12 | 2017-02-28 | Cameron Health Inc. | Cardiac signal vector selection with monophasic and biphasic shape consideration |
US9554714B2 (en) | 2014-08-14 | 2017-01-31 | Cameron Health Inc. | Use of detection profiles in an implantable medical device |
US10369372B2 (en) | 2014-10-21 | 2019-08-06 | Medtronic, Inc. | Recovery of cardiac event sensing and rhythm detection following electrical stimulation pulse delivery |
US9682244B2 (en) | 2014-10-21 | 2017-06-20 | Medtronic, Inc. | Cardiac event sensing and pacing after delivery of an electrical stimulation pulse |
US9993171B2 (en) | 2015-04-08 | 2018-06-12 | Cameron Health, Inc. | Automated screening methods and apparatuses for implantable medical devices |
US20220386928A1 (en) * | 2021-06-03 | 2022-12-08 | Reynolds Delgado | Apparatus for Early Detection of Cardiac Amyloidosis |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4708144A (en) * | 1986-10-06 | 1987-11-24 | Telectronics N.V. | Automatic sensitivity control for a pacemaker |
EP0321764A1 (en) * | 1987-12-23 | 1989-06-28 | Siemens-Elema AB | Method and means for detecting events in a signal |
US4940054A (en) * | 1988-04-29 | 1990-07-10 | Telectronics N.V. | Apparatus and method for controlling multiple sensitivities in arrhythmia control system including post therapy packing delay |
US4972835A (en) * | 1989-05-19 | 1990-11-27 | Ventritex, Inc. | Implantable cardiac defibrillator employing an improved sensing system with non-binary gain changes |
US5103819A (en) * | 1990-06-20 | 1992-04-14 | Intermedics, Inc. | Implantable cardiac stimulator with state machine for automatically controlling gain |
US5117824A (en) * | 1990-11-14 | 1992-06-02 | Medtronic, Inc. | Apparatus for monitoring electrical physiologic signals |
US5269300A (en) * | 1992-07-30 | 1993-12-14 | Cardiac Pacemakers, Inc. | Automatic sensitivity control in an implantable cardiac rhythm management system |
US5339820A (en) * | 1991-12-23 | 1994-08-23 | Ela Medical | Implantable cardiac monitoring and/or control devices having automatic sensitivity control, apparatus and methods therefor |
US5370124A (en) * | 1992-07-31 | 1994-12-06 | Siemens Aktiengesellschaft | Cardiac assist device and method, including detection of heart events |
EP0653225A1 (en) * | 1993-11-17 | 1995-05-17 | ELA MEDICAL (Société anonyme) | Automatic threshold detection of the cardiac rate for use in an implantable device |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3590811A (en) * | 1968-12-06 | 1971-07-06 | American Optical Corp | Electrocardiographic r-wave detector |
US3939824A (en) * | 1973-10-09 | 1976-02-24 | General Electric Company | Physiological waveform detector |
US3878833A (en) * | 1973-10-09 | 1975-04-22 | Gen Electric | Physiological waveform detector |
US3927677A (en) * | 1974-07-12 | 1975-12-23 | Medtronic Inc | Demand cardiac pacer |
US3999556A (en) * | 1974-12-16 | 1976-12-28 | Medtronic, Inc. | Demand cardiac pacemaker with input circuit portion of increased sensitivity |
US3986496A (en) * | 1975-03-06 | 1976-10-19 | Medtronic, Inc. | Apparatus for sensing and transmitting a pacemaker's stimulating pulse |
US4250883A (en) * | 1978-11-06 | 1981-02-17 | Medtronic, Inc. | Digital cardiac pacemaker with refractory, reversion and sense reset means |
US4226245A (en) * | 1978-11-06 | 1980-10-07 | Medtronic, Inc. | System for detecting heart pacemaker pulses |
DE2853642A1 (en) * | 1978-12-09 | 1980-06-12 | Biotronik Mess & Therapieg | AMPLITUDE CONTROL UNIT FOR ECG SIGNALS |
US4240442A (en) * | 1979-01-05 | 1980-12-23 | American Optical Corporation | Variable threshold R-wave detector |
US4722351A (en) * | 1981-12-21 | 1988-02-02 | American Home Products Corporation | Systems and methods for processing physiological signals |
US4665919A (en) * | 1983-03-14 | 1987-05-19 | Vitafin N.V. | Pacemaker with switchable circuits and method of operation of same |
JPS6145734A (en) * | 1984-08-11 | 1986-03-05 | 株式会社アドバンス | R-wave detector of electrocardiograph |
US4617938A (en) * | 1984-12-26 | 1986-10-21 | Yair Shimoni | Method and system for distinguishing R-wave electrocardiograph signals for synchronizing purposes |
US4766902A (en) * | 1986-06-04 | 1988-08-30 | Telectronics N.V. | Automatic sensitivity control for cardiac pacer |
US4768511A (en) * | 1986-07-10 | 1988-09-06 | Telectronics N.V. | Automatic sensitivity control for implantable cardiac pacemakers |
DE3631155A1 (en) * | 1986-09-12 | 1988-03-24 | Alt Eckhard | FREQUENCY VARIABLE HEART PACEMAKER WITH STRESS-ADEQUATE FREQUENCY BEHAVIOR |
US4779617A (en) * | 1986-10-06 | 1988-10-25 | Telectronics N.V. | Pacemaker noise rejection system |
US4819643A (en) * | 1986-11-18 | 1989-04-11 | Mieczyslaw Mirowski | Method and apparatus for cardioverter/pacer featuring a blanked pacing channel and a rate detect channel with AGC |
US4827934A (en) * | 1987-10-27 | 1989-05-09 | Siemens-Pacesetter, Inc. | Sensing margin detectors for implantable electromedical devices |
GB2214813A (en) * | 1988-01-14 | 1989-09-13 | Stuart Charles Webb | Rate-responsive pacemaker |
DE68928715T2 (en) * | 1988-04-29 | 1999-01-21 | Telectronics Nv | Device for ending tachyarrhythmias, including post-therapy stimulation delay |
US4903699A (en) * | 1988-06-07 | 1990-02-27 | Intermedics, Inc. | Implantable cardiac stimulator with automatic gain control |
US4880004A (en) * | 1988-06-07 | 1989-11-14 | Intermedics, Inc. | Implantable cardiac stimulator with automatic gain control and bandpass filtering in feedback loop |
US4934376A (en) * | 1988-06-10 | 1990-06-19 | Siemens Medical Electronics, Inc. | Method and apparatus for detecting heartbeats |
US4967747A (en) * | 1989-05-19 | 1990-11-06 | Ventritex, Inc. | Implantable cardiac defibrillator employing a switched capacitor gain/filter stage having a transient-free gain change |
EP0399059B2 (en) * | 1989-05-22 | 2003-08-20 | St. Jude Medical AB | Implantable medical device with adjustable sensitivity to detect an event relating to a physiological function, and process for using same |
US5010887A (en) * | 1989-11-17 | 1991-04-30 | Siemens-Pacesetter, Inc. | Noise discrimination in implantable pacemakers |
US5097832A (en) * | 1990-03-09 | 1992-03-24 | Siemens-Pacesetter, Inc. | System and method for preventing false pacemaker pvc response |
US5374282A (en) * | 1991-10-31 | 1994-12-20 | Medtronic, Inc. | Automatic sensitivity adjust for cardiac pacemakers |
AU5205493A (en) * | 1992-12-01 | 1994-06-16 | Siemens Aktiengesellschaft | Cardiac event detection in implantable medical devices |
US5354316A (en) * | 1993-01-29 | 1994-10-11 | Medtronic, Inc. | Method and apparatus for detection and treatment of tachycardia and fibrillation |
US5330508A (en) * | 1993-03-02 | 1994-07-19 | Medtronic, Inc. | Apparatus for detection and treatment of tachycardia and fibrillation |
US5458621A (en) * | 1994-03-15 | 1995-10-17 | Incontrol, Inc. | Automatic gain control and method for enabling detection of low and high amplitude depolarization activation waves of the heart and atrial defibrillator utilizing the same |
US5470342A (en) * | 1994-04-12 | 1995-11-28 | Pacesetter, Inc. | Adaptive refractory period within implantable cardioverter-defibrillator |
-
1995
- 1995-08-14 US US08/514,929 patent/US5658317A/en not_active Expired - Lifetime
-
1996
- 1996-08-14 WO PCT/US1996/013181 patent/WO1997006851A1/en not_active Application Discontinuation
- 1996-08-14 EP EP96928864A patent/EP0844898A1/en not_active Ceased
- 1996-08-14 CA CA002228578A patent/CA2228578A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4708144A (en) * | 1986-10-06 | 1987-11-24 | Telectronics N.V. | Automatic sensitivity control for a pacemaker |
EP0321764A1 (en) * | 1987-12-23 | 1989-06-28 | Siemens-Elema AB | Method and means for detecting events in a signal |
US4940054A (en) * | 1988-04-29 | 1990-07-10 | Telectronics N.V. | Apparatus and method for controlling multiple sensitivities in arrhythmia control system including post therapy packing delay |
US4972835A (en) * | 1989-05-19 | 1990-11-27 | Ventritex, Inc. | Implantable cardiac defibrillator employing an improved sensing system with non-binary gain changes |
US5103819A (en) * | 1990-06-20 | 1992-04-14 | Intermedics, Inc. | Implantable cardiac stimulator with state machine for automatically controlling gain |
US5117824A (en) * | 1990-11-14 | 1992-06-02 | Medtronic, Inc. | Apparatus for monitoring electrical physiologic signals |
US5339820A (en) * | 1991-12-23 | 1994-08-23 | Ela Medical | Implantable cardiac monitoring and/or control devices having automatic sensitivity control, apparatus and methods therefor |
US5269300A (en) * | 1992-07-30 | 1993-12-14 | Cardiac Pacemakers, Inc. | Automatic sensitivity control in an implantable cardiac rhythm management system |
US5370124A (en) * | 1992-07-31 | 1994-12-06 | Siemens Aktiengesellschaft | Cardiac assist device and method, including detection of heart events |
EP0653225A1 (en) * | 1993-11-17 | 1995-05-17 | ELA MEDICAL (Société anonyme) | Automatic threshold detection of the cardiac rate for use in an implantable device |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049451A1 (en) * | 1996-06-26 | 1997-12-31 | Medtronic, Inc. | Gain control for a periodic signal and method regarding same |
US5895360A (en) * | 1996-06-26 | 1999-04-20 | Medtronic, Inc. | Gain control for a periodic signal and method regarding same |
EP2510975A1 (en) * | 2011-04-14 | 2012-10-17 | BIOTRONIK SE & Co. KG | Cardiac stimulator |
US9238147B2 (en) | 2011-04-14 | 2016-01-19 | Biotronik Se & Co. Kg | Cardiac stimulator |
Also Published As
Publication number | Publication date |
---|---|
EP0844898A1 (en) | 1998-06-03 |
CA2228578A1 (en) | 1997-02-27 |
US5658317A (en) | 1997-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5658317A (en) | Threshold templating for digital AGC | |
US5620466A (en) | Digital AGC using separate gain control and threshold templating | |
US5662688A (en) | Slow gain control | |
US6029086A (en) | Automatic threshold sensitivity adjustment for cardiac rhythm management devices | |
EP1656182B1 (en) | System and method for noise measurement in an implantable cardiac device | |
US5685315A (en) | Cardiac arrhythmia detection system for an implantable stimulation device | |
US5513644A (en) | Cardiac arrhythmia detection system for an implantable stimulation device | |
EP0744190B1 (en) | Implantable antitachycardia stimulation device | |
US7392087B2 (en) | Method and apparatus for adjusting the sensing threshold of a cardiac rhythm management device | |
US5718242A (en) | Cardiac arrhythmia detection system for an implantable stimulation device and method | |
EP1427473B1 (en) | Multiple templates for filtering of far field r-waves | |
US5365932A (en) | Cardiac signal sensing device having sensitivity automatically controlled in response to metabolic demand | |
US8340768B2 (en) | Sensing threshold control to limit amplitude tracking | |
US5103819A (en) | Implantable cardiac stimulator with state machine for automatically controlling gain | |
US7136705B1 (en) | Method and apparatus for monitoring sensor performance during rate-responsive cardiac stimulation | |
US6738665B2 (en) | Detection of late atrial extrasystoles in an active implantable medical device such as pacemaker defibrillator, cardiovertor and/or multisite device | |
US8000790B2 (en) | Device for adjusting the sensitivity level of an implantable medical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996928864 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2228578 Country of ref document: CA Ref country code: CA Ref document number: 2228578 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1996928864 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1996928864 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996928864 Country of ref document: EP |